Sivaprasad, Sobha http://orcid.org/0000-0001-8952-0659
Ghanchi, Faruque http://orcid.org/0000-0002-4448-8162
Kelly, Simon P.
Kotagiri, Ajay
Talks, James http://orcid.org/0000-0001-6126-6476
Scanlon, Peter http://orcid.org/0000-0001-8513-710X
McGoey, Hellen
Nolan, Andrew http://orcid.org/0000-0003-0799-2914
Saddiq, Moneeb
Napier, Jackie
,
Funding for this research was provided by:
The DRAKO study was sponsored by Bayer UK.
Article History
Received: 22 December 2020
Revised: 6 May 2021
Accepted: 2 June 2021
First Online: 9 July 2021
Competing interests
: SS received consultancy fees from Bayer, Allergan, Novartis Pharma AG, Roche, Boehringer Ingelheim, Optos, Apellis, Oxurion, Biogen, Oculis and Heidelberg Engineering. SS is Editor-in-Chief for the Journal Eye. Faruque Ghanchi has been a consultant and speaker for Novartis, Bayer, Allergan, Alimera and Roche; and has received travel grants from Bayer and Novartis. SPK received travel grants from Bayer, research support from Bayer and Novartis Pharma AG, and participated in advisory boards for Novartis Pharma AG and Polyphotopics. AK received travel support from Novartis, Bayer, and Allergan, and speaker fees from Allergan and Bayer. JT participated in advisory boards for Bayer and Novartis; received travel support from Bayer; and received research grants from Bayer, Novartis and Roche. PS attended advisory boards for Pfizer, Allergan, Boehringer, Roche and Bayer, and his department has received educational, research, and audit grants from Allergan, Boehringer Ingelheim, Novartis, and Bayer. HM is an employee of Bayer Plc. AN is an employee of Bayer Plc. MS is an employee of O4 Research. JN is an employee of Bayer Plc.